Future oncology (London, England) · 2015
Molecular features and clinical outcome of lung malignancies in very young people.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Catania Chiara, Botteri Edoardo, Barberis Massimo, Conforti Fabio, Toffalorio Francesca, De Marinis Filippo, Boselli Sabrina, Noberasco Cristina, Delmonte Angelo, Spitaleri Gianluca, Spaggiari Lorenzo, Rotmensz Nicole, Passaro Antonio, Bazolli Barbara, Alfieri Marina, Manzotti Michela, Fumagalli Caterina, Milani Alessandra, De Pas Tommaso
Аннотация
INTRODUCTION: We describe the clinical features, outcome and incidence of druggable targets of lung cancers in patients ≤ 40 years old.
MATERIALS & METHODS: Young patients were compared with two other groups (41-64 and ≥ 65 years). Neuroendocrine tumors, adenocarcinoma and non-adenocarcinoma/unspecified non-small-cell lung cancer were analyzed separately. Molecular characteristics of adenocarcinoma were evaluated in a subset of young patients.
RESULTS: Of 2847 patients with lung cancer, 100 were ≤ 40 years old. The young group contained more women, never-smokers and patients presenting with advanced disease. The commonest tumor in young patients was adenocarcinoma. In total, 19 of 34 young patients with adenocarcinoma had tumors with specific molecular alterations.
CONCLUSION: Lung cancers in young patients have distinctive features but outcomes similar to those in older patients.
MATERIALS & METHODS: Young patients were compared with two other groups (41-64 and ≥ 65 years). Neuroendocrine tumors, adenocarcinoma and non-adenocarcinoma/unspecified non-small-cell lung cancer were analyzed separately. Molecular characteristics of adenocarcinoma were evaluated in a subset of young patients.
RESULTS: Of 2847 patients with lung cancer, 100 were ≤ 40 years old. The young group contained more women, never-smokers and patients presenting with advanced disease. The commonest tumor in young patients was adenocarcinoma. In total, 19 of 34 young patients with adenocarcinoma had tumors with specific molecular alterations.
CONCLUSION: Lung cancers in young patients have distinctive features but outcomes similar to those in older patients.
Предметные рубрики MeSH
AdenocarcinomaAdolescentAdultAge FactorsAgedAged, 80 and overCarcinoid TumorCarcinoma, Large CellCarcinoma, Non-Small-Cell LungErbB ReceptorsFemaleHumansIn Situ Hybridization, FluorescenceLung NeoplasmsMaleMiddle AgedNuclear ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)Erb-b2 Receptor Tyrosine KinasesSmall Cell Lung CarcinomaSurvival RateTranscription FactorsYoung Adultras Proteins